title: Effect of iron chelators on dopamine D2 receptors.
abstract: Nutritional iron deficiency induced in rats causes a selective reduction of [3H]spiperone binding in caudate nucleus. This effect can be reversed by iron supplementation in vivo. The possibility that iron may be involved in the dopamine D2 receptor was investigated by examining the effect of various iron and noniron chelators on the binding of [3H]spiperone in rat caudate nucleus. Iron chelators 1,10-phenanthroline, 2,4,6-tripyridyl-s-triazine, alpha, alpha'-dipyridyl, and desferrioxamine mesylate inhibited the binding of [3H]spiperone. The inhibition by 1,10-phenanthroline was noncompetitive and reversible. In the presence of FeCl2 or FeCl3, the inhibitory effect of 1,10-phenanthroline was potentiated. Iron salts or chelators were without effect on the binding of [3H]dihydroalprenolol to beta-adrenoreceptors in caudate nucleus; thus the action of iron chelators on the dopamine D2 receptor tends to be selective. Incubation of caudate nucleus membrane prepared from iron-deficient rats with FeCl2 or FeCl3 did not reverse the diminished binding of [3H]spiperone. The present study indicates that if iron is involved in the physiological regulation of dopamine D2 agonist-antagonist binding sites, it is more complex than hitherto considered.
authors.forename: D
authors.initials: D
authors.lastname: Ben-Shachar
authors.forename: J P
authors.initials: JP
authors.lastname: Finberg
authors.forename: M B
authors.initials: MB
authors.lastname: Youdim
mesh_terms: D015082:2,2'-Dipyridyl / Q000494:pharmacology; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000818:Animals; D002421:Caudate Nucleus / Q000378:metabolism; D003300:Copper / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D004082:Dihydroalprenolol / Q000378:metabolism; D005296:Ferrous Compounds / Q000494:pharmacology; D007502:Iron Chelating Agents / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009571:Nitrilotriacetic Acid / Q000494:pharmacology; D010618:Phenanthrolines / Q000494:pharmacology; D010659:Phenylhydrazines; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D011954:Receptors, Dopamine / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism; D014227:Triazines / Q000494:pharmacology
chemical_list: D005296:Ferrous Compounds; D007502:Iron Chelating Agents; D010618:Phenanthrolines; D010659:Phenylhydrazines; D011943:Receptors, Adrenergic, beta; D011954:Receptors, Dopamine; D014227:Triazines; C030299:phenylhydrazine; D013134:Spiperone; D015082:2,2'-Dipyridyl; D004082:Dihydroalprenolol; D003300:Copper; C028419:cuprous chloride; D003676:Deferoxamine; D009571:Nitrilotriacetic Acid; C029451:ferrous chloride; C025205:1,10-phenanthroline; C002849:2,4,6-tripyridyl-s-triazine